Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Strategy
MSTR
US Stock MarketDetailed Quotes
ADTX Aditxt
- 0.0560
- +0.0045+8.74%
Close Mar 10 16:00 ET
- 0.0534
- -0.0026-4.64%
Pre 07:25 ET
4.42MMarket Cap0.00P/E (TTM)
0.0592High0.0513Low56.72MVolume0.0539Open0.0515Pre Close3.12MTurnover71.89%Turnover Ratio0.00P/E (Static)78.89MShares218.000052wk High0.93P/B4.42MFloat Cap0.042752wk Low--Dividend TTM78.89MShs Float766400.0000Historical High--Div YieldTTM15.34%Amplitude0.0427Historical Low0.0540Avg Price1Lot Size
About Aditxt Company
Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore. The company was founded by Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna on September 28, 2017 and is headquartered in Richmond, VA.
Company Profile
SymbolADTX
Company NameAditxt
Listing DateJun 30, 2020
Founded2017
CEOMr. Amro A. Albanna
MarketNASDAQ
Employees47
Fiscal Year Ends12-31
Address737 North Fifth Street,Suite 200
CityRichmond
ProvinceVirginia
CountryUnited States of America
Zip Code23219
Phone1-650-870-1200
Websitehttp://www.aditxt.com
Company Executives
- Name
- Position
- Salary
- Amro A. Albanna
- Chairman of the Board and Chief Executive Officer
- 519.23K
- Dr. Shahrokh Shabahang, D.D.S.,M.S.,PhD
- Director and Chief Innovation Officer
- 358.84K
- Corinne Pankovcin
- Chief Mergers and Acquisitions Officer
- 390.33K
- Thomas J. Farley
- Chief Financial Officer and Principal Accounting Officer
- 381.45K
- Rowena Albanna
- Chief Operating Officer
- --
- Sylvia Hermina
- Director
- --
- Brian Brady
- Independent Director
- 3.86K
- Dr. Jeffrey W. Runge, M.D.
- Independent Director
- 3.86K
- Charles Athle Nelson
- Independent Director
- --